Skip to main content

Table 4 Details of cases of loss of consciousness on the manufacturer’s reports of adverse events

From: Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report

Sex Age Relationship with Cet Outcome Period from the infusion Diagnosis (metastatic site) Concomitant drug Under investigation
Female 60 Yes Recovered 5 min Colon cancer (peritoneum, lymph nodes) Dexamethasone, Azasetron  
Male 80 Yes Recovered 1 day Colon cancer (liver) Chlorpheniramine, Dexamethasone, Granisetron  
Male 70 Yes Not recovered Not mentioned Colon cancer Fluorouracil, calcium folinate, oxaliplatin Yes
  1. Cet cetuximab, DEX dexamethasone sodium phosphate, Azasetron azasetron hydrochloride, Chlorpheniramine chlorpheniramine maleate, Granisetron granisetron hydrochloride